INVITRO ACTIVITY OF ENOXACIN (CI-919), A NEW QUINOLINE DERIVATIVE, COMPARED WITH THAT OF OTHER ANTIMICROBIAL AGENTS

被引:85
作者
WISE, R
ANDREWS, JM
DANKS, G
机构
关键词
D O I
10.1093/jac/13.3.237
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:237 / 244
页数:8
相关论文
共 8 条
[1]   INVITRO ACTIVITY OF CI-919 (AT-2266), AN ORAL ANTI-PSEUDONOMAL COMPOUND [J].
CHARTRAND, SA ;
SCRIBNER, RK ;
WEBER, AH ;
WELCH, DF ;
MARKS, MI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :658-663
[2]   NALIDIXIC-ACID - ANTIBACTERIAL PARADOX [J].
CRUMPLIN, GC ;
SMITH, JT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (03) :251-261
[3]   ACTIVITY OF AT-2266 COMPARED WITH THOSE OF NORFLOXACIN, PIPEMIDIC ACID, NALIDIXIC-ACID, AND GENTAMICIN AGAINST VARIOUS EXPERIMENTAL INFECTIONS IN MICE [J].
NAKAMURA, S ;
NAKATA, K ;
KATAE, H ;
MINAMI, A ;
KASHIMOTO, S ;
YAMAGISHI, J ;
TAKASE, Y ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :742-749
[4]   NORFLOXACIN AND THE ANTIBACTERIAL GAMMA-PYRIDONE BETA-CARBOXYLIC ACIDS [J].
NEWSOM, SWB ;
MATTHEWS, J ;
AMPHLETT, M ;
WARREN, RE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (01) :25-30
[5]  
PEDRINI AM, 1979, ANTIBIOTICS 1, V5, P154
[6]  
Richmond M H, 1973, Adv Microb Physiol, V9, P31, DOI 10.1016/S0065-2911(08)60376-8
[7]   INVITRO AND INVIVO ACTIVITY OF DL-8280, A NEW OXAZINE DERIVATIVE [J].
SATO, K ;
MATSUURA, Y ;
INOUE, M ;
UNE, T ;
OSADA, Y ;
OGAWA, H ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) :548-553
[8]   INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].
WISE, R ;
ANDREWS, JM ;
EDWARDS, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564